The Potential Role of Metabolic Disease in Liver Tumorigenesis in Patients With Hepatitis B Surface Antigen Seroclearance

Clin Gastroenterol Hepatol. 2019 May;17(6):1216-1217. doi: 10.1016/j.cgh.2018.11.020.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinogenesis
  • Carcinoma, Hepatocellular*
  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens
  • Hepatitis B, Chronic*
  • Humans
  • Liver Neoplasms*
  • Metabolic Diseases*

Substances

  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens